Pasithea Therapeutics Corp. (KTTAW) NASDAQ
0.01
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.01
+0(+0.00%)
Currency In USD
| Market Cap | 3.45M |
| Enterprise Value | -3.47M |
| P/E Ratio | -0.45 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.5 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.15 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.99 |
| Return On Equity | -0.98 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.6M |
| Net Income | -13.9M |
| Diluted EPS | -12.69 |
| Total Cash | 4.12M |
| Total Cash/Share | 0.55 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.02 |
| Book Value Per Share | 1.64 |
| 52-Week Change | -40.11 |
| 52-Week High | 0.01 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0.02 |
| Moving Average 200 Days | 0.02 |
| Average Volume | 40,167.74 |
| Shares Outstanding | 7.44M |
| % Held by Institutions | 6.25 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |